Business Segments · Revenue

OM&R — Revenue

Ventas OM&R — Revenue increased by 1.5% to $230.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 4.0%, from $222.00M to $230.90M. Over 3 years (FY 2021 to FY 2025), OM&R — Revenue shows an upward trend with a 3.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityStable
First reportedQ1 2021
Last reportedQ1 2026
Rolls up toTotal Revenue

How to read this metric

An increase indicates higher occupancy or rental rate growth, while a decrease suggests declining demand or vacancy issues.

Detailed definition

The total gross revenue generated by the Outpatient Medical and Research segment, primarily consisting of rental income...

Peer comparison

Standard top-line revenue metric for real estate segments across all REITs.

Metric ID: vtr_segment_om_r_revenues

Historical Data

18 periods
 Q2 '21Q3 '21Q4 '21Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$200.67M$200.67M$200.67M$199.91M$201.41M$203.63M$216.37M$226.99M$222.72M$219.51M$219.56M$221.58M$216.95M$222.00M$221.49M$226.88M$227.54M$230.90M
QoQ Change+0.0%+0.0%-0.4%+0.8%+1.1%+6.3%+4.9%-1.9%-1.4%+0.0%+0.9%-2.1%+2.3%-0.2%+2.4%+0.3%+1.5%
YoY Change-0.4%+0.4%+8.2%+12.7%+7.8%+1.5%-2.4%-2.6%+1.1%+0.9%+2.4%+4.9%+4.0%
Range$199.91M$230.90M
CAGR+3.4%
Avg YoY Growth+3.0%
Median YoY Growth+1.5%
Current Streak3 quarters growth

Frequently Asked Questions

What is Ventas's om&r — revenue?
Ventas (VTR) reported om&r — revenue of $230.90M in Q1 2026.
How has Ventas's om&r — revenue changed year-over-year?
Ventas's om&r — revenue increased by 4.0% year-over-year, from $222.00M to $230.90M.
What is the long-term trend for Ventas's om&r — revenue?
Over 3 years (2021 to 2025), Ventas's om&r — revenue has grown at a 3.8% compound annual growth rate (CAGR), from $802.68M to $897.90M.
What does om&r — revenue mean?
Total gross income generated by the outpatient medical and research properties.